Related Experiment Video
Updated: Jun 5, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy
Joshua K Meisner1, Aaron Renberg2, Eric D Smith3
1Department of Pediatrics, Division of Pediatric Cardiology (J.K.M., M.W.R.), University of Michigan, Ann Arbor.
Insights
Low penetrance sarcomere variants (LowSVs) are common and contribute to hypertrophic cardiomyopathy (HCM) risk. Combined with pathogenic variants, LowSVs significantly increase HCM severity and influence age-related cardiac remodeling.
Area of Science:
- Cardiovascular Genetics
- Human Genetics
- Molecular Cardiology
Background:
- Hypertrophic cardiomyopathy (HCM) traditionally viewed as monogenic, caused by rare, highly penetrant sarcomere variants.
- Polygenic contributions are increasingly recognized, but low penetrance sarcomere variants (LowSVs) remain understudied.
- LowSVs are common, intermediate frequency variants with moderate effect sizes, hypothesized to influence HCM risk and severity.
Purpose of the Study:
- Systematically investigate the role of LowSVs in hypertrophic cardiomyopathy (HCM).
- Define LowSVs based on population frequency and enrichment in HCM patients.
- Assess the association of LowSVs with disease severity, clinical outcomes, and HCM-adjacent traits.
Main Methods:
- Identified LowSVs from the Sarcomeric Human Cardiomyopathy Registry (SHaRe) using defined frequency and enrichment criteria.
- Analyzed LowSV association with HCM severity and outcomes.
- Assessed functional impact of selected LowSVs using patient-derived cardiomyocytes.
- Correlated LowSVs with HCM-adjacent traits in the general population using UK Biobank data.
Main Results:
- Identified 12 LowSVs, collectively common in the general population (1:350) and enriched in HCM patients.
- Isolated LowSVs associated with later HCM diagnosis and fewer adverse events.
- LowSVs combined with pathogenic variants significantly increased morbidity (HR 5.4) compared to single pathogenic variants (HR 2.0).
- Validated intermediate functional impact for specific LowSVs (MYBPC3, TNNT2).
- Five LowSVs associated with HCM-adjacent traits in the general population without overt HCM.
Conclusions:
- Established LowSVs as a distinct class of common, low penetrance variants influencing HCM.
- Isolated LowSVs contribute to milder HCM phenotypes.
- Combined effects of LowSVs and pathogenic variants significantly exacerbate HCM severity.
- LowSVs contribute to cardiac remodeling even in the absence of overt HCM.
Background:
Classically, hypertrophic cardiomyopathy (HCM) has been viewed as a single-gene (monogenic) disease caused by pathogenic variants in sarcomere genes. Pathogenic sarcomere variants are individually rare and convey high risk for developing HCM (highly penetrant). Recently, important polygenic contributions have also been characterized. Low penetrance sarcomere variants (LowSVs) at intermediate frequencies and effect sizes have not been systematically investigated. We hypothesize that LowSVs may be common in HCM with substantial influence on disease risk and severity.
Methods:
Among all sarcomere variants observed in the Sarcomeric Human Cardiomyopathy Registry (SHaRe), we identified putative LowSVs defined by (1) population frequency greater than expected for highly penetrant (monogenic) HCM (allele frequency >5×10-5 in the Genome Aggregation Database, gnomAD) and (2) moderate enrichment (>2×) in patients with HCM compared with gnomAD. LowSVs were examined for their association with disease severity and clinical outcomes. Functional effects of selected LowSVs were assessed using induced pluripotent stem cell-derived cardiomyocytes. Association of LowSVs with HCM-adjacent traits in the general population was tested using UK Biobank cardiac magnetic resonance imaging data.
Results:
Among 6045 patients and 1159 unique variants in sarcomere genes, 12 LowSVs were identified. LowSVs were collectively common in the general population (1:350) and moderately enriched in HCM (aggregate odds ratio, 14.9 [95% CI, 12.5-17.9]). Isolated LowSVs were associated with an older age of HCM diagnosis and fewer adverse events. However, LowSVs in combination with a pathogenic sarcomere variant conferred higher morbidity (eg, composite adverse event hazard ratio, 5.4 [95% CI, 3.0-9.8] versus single pathogenic sarcomere variant, 2.0 [95% CI, 1.8-2.2]; P<0.001). An intermediate functional impact was validated for 2 specific LowSVs-MYBPC3 c.442G>A (partial splice gain) and TNNT2 c.832C>T (intermediate effect on contractile mechanics). Cardiac magnetic resonance imaging analysis of the general population revealed 5 of 12 LowSVs were significantly associated with HCM-adjacent traits without overt HCM.
Conclusions:
This study establishes a new class of low penetrance sarcomere variants that are relatively common in the population. When penetrant, isolated LowSVs cause mild HCM. In combination with pathogenic sarcomere variants, LowSVs markedly increase disease severity, supporting a clinically significant additive effect. Last, LowSVs also contribute to age-related remodeling even in the absence of overt HCM.
Related Concept Videos
Multiple Allele Traits
Pathophysiology of Heart Failure
The Sarcomere
Each...
Pedigree Analysis
Incomplete Dominance
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

